Publications en collaboration avec des chercheurs de Universitat de Barcelona (42)

2024

  1. Impact of primary aldosteronism on kidney function: Results from the SPAIN-ALDO registry

    Journal of Hypertension, Vol. 42, Núm. 10, pp. 1805-1812

  2. Renin as a Biomarker to Guide Medical Treatment in Primary Aldosteronism Patients. Findings from the SPAIN-ALDO Registry

    High Blood Pressure and Cardiovascular Prevention, Vol. 31, Núm. 1, pp. 43-53

2023

  1. Downregulated Adipose Tissue Expression of Browning Genes With Increased Environmental Temperatures

    The Journal of clinical endocrinology and metabolism, Vol. 109, Núm. 1, pp. e145-e154

  2. Effect of Obesity on Clinical Characteristics of Primary Aldosteronism Patients at Diagnosis and Postsurgical Response

    The Journal of clinical endocrinology and metabolism, Vol. 109, Núm. 1, pp. e379-e388

2022

  1. Impact of COVID-19 Lockdown in Eating Disorders: A Multicentre Collaborative International Study

    Nutrients, Vol. 14, Núm. 1

2021

  1. Adipose tissue knockdown of lysozyme reduces local inflammation and improves adipogenesis in high-fat diet-fed mice

    Pharmacological Research, Vol. 166

  2. Alterations in slc4a2, slc26a7 and slc26a9 drive acid–base imbalance in gastric neuroendocrine tumors and uncover a novel mechanism for a co-occurring polyautoimmune scenario

    Cells, Vol. 10, Núm. 12

  3. Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)1

    Autophagy, Vol. 17, Núm. 1, pp. 1-382

  4. Transdiagnostic perspective of impulsivity and compulsivity in obesity: From cognitive profile to self-reported dimensions in clinical samples with and without diabetes

    Nutrients, Vol. 13, Núm. 12

2020

  1. COVID Isolation Eating Scale (CIES): Analysis of the impact of confinement in eating disorders and obesity—A collaborative international study

    European Eating Disorders Review

  2. Liver CPT1A gene therapy reduces diet-induced hepatic steatosis in mice and highlights potential lipid biomarkers for human NAFLD

    FASEB Journal, Vol. 34, Núm. 9, pp. 11816-11837

2019

  1. Associations between neuropsychological performance and appetite-regulating hormones in anorexia nervosa and healthy controls: Ghrelin's putative role as a mediator of decision-making

    Molecular and Cellular Endocrinology, Vol. 497

  2. Cytoskeletal transgelin 2 contributes to gender-dependent adipose tissue expandability and immune function

    FASEB Journal, Vol. 33, Núm. 8, pp. 9656-9671

  3. Reduced Plasma Orexin-A Concentrations are Associated with Cognitive Deficits in Anorexia Nervosa

    Scientific Reports, Vol. 9, Núm. 1

2018

  1. COSMIC project: Consensus on the objectives of the metabolic syndrome in clinic

    Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy, Vol. 11, pp. 683-697

2017

  1. An increase in visceral fat is associated with a decrease in the taste and olfactory capacity

    PLoS ONE, Vol. 12, Núm. 2

  2. FGF19 and FGF21 serum concentrations in human obesity and type 2 diabetes behave differently after diet- or surgically-induced weight loss

    Clinical Nutrition, Vol. 36, Núm. 3, pp. 861-868

  3. Fibroblast growth factor 15/19 (FGF15/19) protects from diet-induced hepatic steatosis: Development of an FGF19-based chimeric molecule to promote fatty liver regeneration

    Gut, Vol. 66, Núm. 10, pp. 1818-1828

2016

  1. A Lower Olfactory Capacity Is Related to Higher Circulating Concentrations of Endocannabinoid 2-Arachidonoylglycerol and Higher Body Mass Index in Women

    PLoS ONE, Vol. 11, Núm. 2

  2. Decision making impairment: A shared vulnerability in obesity, gambling disorder and substance use disorders?

    PLoS ONE, Vol. 11, Núm. 9